3 results
Not approvedWill not start
The objective is to investigate the accuracy, feasibility and safety of FFR in patients presenting with STEMI and MVD.
Approved WMOCompleted
The primary objectives are to determine the maximum tolerated dose (MTD) and/or recommended phase two dose (RP2D) of ABBV-621 and to evaluate pharmacokinetics (PK) of (A) single agent ABBV-621; and (B) the combination of ABBV-621 and venetoclax in…
Approved WMOCompleted
To evaluate the safety and efficacy of ReActiv8 for the treatment of adults with Chronic Low Back Pain and no prior spine surgery when used in conjunction with medical management.